Norris Medicines Ltd

NSE: NORRIS · BSE: 524414 · Pharmaceuticals & Biotechnology · 9 announcements

Share price: ₹15.58
Market cap: ₹15.58 Cr
Revenue (annual): ₹8.13 Cr
Net profit (annual): ₹-0.28 Cr
P/E (TTM): -42.5×Sector 47.3×
Promoter holding: 34.01%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Financial Results 3 Board Meeting Date 2 Other Announcement 1 Management Change 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

14 Aug 2026 17:19 IST BSE

Financial Results

Norris Medicines Q1 FY27 Results: Net Loss of ₹0.4 Cr, Loss Widens

Norris Medicines Ltd reported revenue from operations of ₹0.9 Cr (-40.0% YoY) and a net loss of ₹0.4 Cr for Q1 FY27.

Key figure: Net loss ₹0.4 Cr

Open full results → Read the filing ↗

30 May 2026 16:18 IST BSE

Financial Results

Norris Medicines Q4 FY26 Results: Turns Profitable, Net Profit ₹0.1 Cr

Norris Medicines Ltd reported revenue from operations of ₹1.4 Cr (-48.1% YoY) and net profit of ₹0.1 Cr for Q4 FY26.

Key figure: Net profit ₹0.1 Cr

Open full results → Read the filing ↗

30 May 2026 16:17 IST BSE

Financial Results

Norris Medicines Financial Results

Norris Medicines Limited approved audited financial results for the year ended March 31, 2026. The company also appointed M/s. Dhiren Y Parikh & Co. as Internal Auditors.

Read the filing ↗